Jeffrey Arcara's most recent trade in Corvus Pharmaceuticals Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | Arcara Jeffrey | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharmaceuticals Inc | Jeffrey Arcara | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |